Cardiovascular Peptide Drug Discovery is a specialized research and development service focused on identifying peptide-based molecules that modulate key biological processes involved in cardiovascular and cardiometabolic diseases.

Oncology Targeting Peptide Library is a specialized peptide discovery resource designed to support precision oncology research and targeted therapeutic development.

Antimicrobial Peptide Screening Service is part of an integrated peptide discovery ecosystem provided by PeptiOrigin. This platform combines ultra-large peptide library technology, high-throughput screening, and computational optimization tools to accelerate the identification of next-generation antimicrobial candidates.

High-throughput peptide screening is a powerful approach for discovering biologically active peptides. However, false positives—peptides that appear active in screening assays but fail to demonstrate true target engagement—can slow down development and increase costs.

Precision medicine aims to tailor therapies to individual patients based on their genetic, proteomic, and molecular profiles.

The development of biologics—therapeutics derived from peptides, proteins, or antibodies—has transformed modern medicine. Among these, peptides have emerged as highly versatile molecules capable of modulating complex biological targets with precision.

Peptides offer unique advantages in cancer research, including high specificity, structural adaptability, and the ability to target protein–protein interactions often inaccessible to small molecules.